Form 4 for CRL Charles River Laboratories
Accepted 2026-07-01 16:59:29 ET · period of report 2026-06-29 · accession 0001100682-26-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-01 16:59 | 2026-06-29 | CRL | FOSTER JAMES C | Dir | S - Sale | $225.00 | -75.0K | 31.6K | -70% | -$16.88M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-29 | S | D | 75,000 | $225.00 | 31,596 | D | — | — | (F1) This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted by the reporting person on March 6, 2026. |